agilon health, inc. (NYSE:AGL) Receives Average Rating of “Hold” from Analysts

Shares of agilon health, inc. (NYSE:AGL) have earned a consensus recommendation of “Hold” from the seventeen ratings firms that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $3.95.

Several equities analysts have recently commented on the company. Macquarie assumed coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Royal Bank of Canada raised their target price on shares of agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Stifel Nicolaus raised their target price on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a report on Wednesday, February 26th. Finally, Sanford C. Bernstein lifted their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th.

agilon health Price Performance

NYSE:AGL opened at $4.08 on Monday. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of -4.34 and a beta of 0.67. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The business has a 50 day simple moving average of $3.30 and a 200-day simple moving average of $2.95. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently bought and sold shares of AGL. Captrust Financial Advisors lifted its holdings in shares of agilon health by 10.9% during the 4th quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock worth $67,000 after acquiring an additional 3,494 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in agilon health by 2.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company’s stock worth $393,000 after purchasing an additional 5,107 shares during the period. MetLife Investment Management LLC raised its stake in agilon health by 4.0% during the fourth quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock worth $332,000 after purchasing an additional 6,762 shares during the period. Symphony Financial Services Inc. raised its stake in agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after purchasing an additional 7,058 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health during the third quarter worth approximately $28,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.